Global routing congestion reduction with cost allocation look-ahead

Author(s):  
Leandro Nunes ◽  
Ricardo Reis
VLSI Design ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-18 ◽  
Author(s):  
Min Pan ◽  
Yue Xu ◽  
Yanheng Zhang ◽  
Chris Chu

Modern large-scale circuit designs have created great demand for fast and high-quality global routing algorithms to resolve the routing congestion at the global level. Rip-up and reroute scheme has been employed by the majority of academic and industrial global routers today, which iteratively resolve the congestion by recreating the routing path based on current congestion. This method is proved to be the most practical routing framework. However, the traditional iterative maze routing technique converges very slowly and easily gets stuck at local optimal solutions. In this work, we propose a very efficient and high-quality global router—FastRoute. FastRoute integrates several novel techniques: fast congestion-driven via-aware Steiner tree construction, 3-bend routing, virtual capacity adjustment, multisource multi-sink maze routing, and spiral layer assignment. These techniques not only address the routing congestion measured at the edges of global routing grids but also minimize the total wirelength and via usage, which is critical for subsequent detailed routing, yield, and manufacturability. Experimental results show that FastRoute is highly effective and efficient to solve ISPD07 and ISPD08 global routing benchmark suites. The results outperform recently published academic global routers in both routability and runtime. In particular, for ISPD07 and ISPD08 global routing benchmarks, FastRoute generates 12 congestion-free solutions out of 16 benchmarks with a speed significantly faster than other routers.


VLSI Design ◽  
2002 ◽  
Vol 15 (3) ◽  
pp. 595-604 ◽  
Author(s):  
Jiang Hu ◽  
Sachin S. Sapatnekar

We propose a heuristic for VLSI interconnect global routing that can optimize routing congestion, delay and number of bends, which are often competing objectives. Routing flexibilities under timing constraints are obtained and exploited to reduce congestion subject to timing constraints. The wire routes are determined through gradual refinement according to probabilistic estimation on congestions so that the congestion is minimized while the number of bends on wires is limited. The experiments on both random generated circuits and benchmark circuits confirm the effectiveness of this method.


2021 ◽  
Vol 122 ◽  
pp. 102888
Author(s):  
Han Zou ◽  
Maged M. Dessouky ◽  
Shichun Hu

2016 ◽  
Vol 15 (1) ◽  
pp. 1-3
Author(s):  
Bernd Marcus
Keyword(s):  

1998 ◽  
Vol 80 (12) ◽  
pp. 887-893 ◽  
Author(s):  
Jacopo Gianetti ◽  
Gianfranco Gensini ◽  
Raffaele De Caterina

SummaryAims. The recent publication of two large trials of secondary prevention of coronary artery disease with oral anticoagulants (WARIS and ASPECT) has caused a revival of the interest for this antithrombotic therapy in a clinical setting where the use of aspirin is common medical practice. Despite this, the preferential use of aspirin has been supported by an American cost-effectiveness analysis (JAMA 1995; 273: 965). Methods and Results. Using the same parameters used in that analysis and incidence of events from the Antiplatelet Trialists Collaboration and the ASPECT study, we re-evaluated the economic odds in favor of aspirin or oral anticoagulants in the Italian Health System, which differs significantly in cost allocation from the United States system and is, conversely, similar to other European settings. Recalculated costs associated with each therapy were 2,150 ECU/ patient/year for oral anticoagulants and 2,187 ECU/patient/year for aspirin. In our analysis, the higher costs of oral anticoagulants versus aspirin due to a moderate excess of bleeding (about 10 ECU/ patient/year) and the monitoring of therapy (168 ECU/ patient/year) are more than offset by an alleged savings for recurrent ischemic syndromes and interventional procedures (249 ECU/ patient/year). Conclusions. Preference of aspirin vs. oral anticoagulants in a pharmaco-economical perspective is highly dependent on the geographical situation whereupon calculations are based. On a pure cost-effectiveness basis, and in the absence of data of direct comparisons between aspirin alone versus I.N.R.-adjusted oral anticoagulants, the latter are not more expensive than aspirin in Italy and, by cost comparisons, in other European countries in the setting of post-myocardial infarction.


1943 ◽  
Vol 12 (23) ◽  
pp. 230-231
Author(s):  
Guenther Stein
Keyword(s):  

2016 ◽  
Vol 136 (10) ◽  
pp. 692-697
Author(s):  
Shuto Higa ◽  
Chikatoshi Yamada ◽  
Kei Miyagi ◽  
Shuichi Ichikawa

Sign in / Sign up

Export Citation Format

Share Document